VGW.CN - Valens GroWorks Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
3.4400
-0.2700 (-7.28%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.7100
Open3.7500
Bid3.4200 x 0
Ask3.4700 x 0
Day's Range3.4000 - 3.7500
52 Week Range0.9800 - 4.9000
Volume647,945
Avg. Volume1,006,130
Market Cap413.849M
Beta (3Y Monthly)6.04
PE Ratio (TTM)N/A
EPS (TTM)-0.2300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Market Exclusive5 days ago

    Cannabis Stock News Daily Roundup June 11

    Valens GroWorks (CSE: VGW) (OTC: VGWCF) has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length binding multi-year agreement with Tilray (NASDAQ: TLRY). Massachusetts' only cannabis company Garden Remedies (GRI) has opened its newest dispensary in Marlborough. The location commenced adult use retail operations and is awaiting […]The post Cannabis Stock News Daily Roundup June 11 appeared first on Market Exclusive.

  • Market Exclusive5 days ago

    Valens Expands Extraction Services Agreement with Tilray

    Valens GroWorks (CSE: VGW) (OTC: VGWCF) has updated its multi-year agreement with Tilray (NASDAQ: TLRY), which is focused on cannabis research, cultivation, production, and distribution. The company has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length, binding agreement announced in February with Tilray. […]The post Valens Expands Extraction Services Agreement with Tilray appeared first on Market Exclusive.

  • Valens Expands Size and Scope of Agreement With Tilray
    PR Newswire6 days ago

    Valens Expands Size and Scope of Agreement With Tilray

    KELOWNA, BC, June 10, 2019 /PRNewswire/ - Valens GroWorks Corp. (CSE: VGW, OTC: VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has expanded the volume of extraction services and has added an option to provide contract manufacturing services to the arm's length, binding multi-year agreement (the "Agreement") previously announced February 26, 2019 with Tilray Inc. ("Tilray") (TLRY), a global leader in cannabis research, cultivation, production and distribution. Under the initial two-year term of the expanded Agreement, Valens will extract on a fee for service basis a minimum annual quantity of 60,000kg of dried cannabis and hemp biomass, up 300% from the 15,000kg annual commitment outlined in the original agreement.

  • PR Newswire10 days ago

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , June 6, 2019 /PRNewswire/ -- Virtual Investor Conferences ...

  • PR Newswire16 days ago

    Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

    Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , May 31, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...

  • Valens signs multi-year cannabis extraction agreement with Tantalus Labs
    PR Newswire19 days ago

    Valens signs multi-year cannabis extraction agreement with Tantalus Labs

    KELOWNA, BC, May 28, 2019 /PRNewswire/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has entered into an arm's length binding multi-year extraction services agreement (the "Agreement") to provide cannabis extraction services to Tantalus Labs ("Tantalus"), a leading British-Columbia-based cannabis producer. The Agreement has an initial 2-year term from the date of the first shipment from Tantalus.

  • Valens Appoints President Focused on Growth Opportunities
    CNW Group20 days ago

    Valens Appoints President Focused on Growth Opportunities

    KELOWNA, BC , May 27, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies including distillation, cannabinoid isolation and purification, product formulation and development as well as associated quality testing announced today that Jeffrey Fallows , LLB/MBA, CFA has been appointed as President of Valens, effective June 1, 2019 .  Mr. Fallows will be focused on executing on domestic and international growth opportunities, capital markets strategy and assisting with the overall corporate strategy of the Company.

  • Leading International Cannabis Expert Joins Valens Board of Directors
    CNW Grouplast month

    Leading International Cannabis Expert Joins Valens Board of Directors

    KELOWNA, B.C. , May 13, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing announced today that Deepak Anand has been appointed to its Board of Directors as an independent member. Mr. Anand is recognized as a thought leader in the global cannabis space.

  • Valens Announces Acceleration of Warrant Expiry Date
    CNW Grouplast month

    Valens Announces Acceleration of Warrant Expiry Date

    KELOWNA, BC , May 2, 2019 /CNW/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing announced today that it is accelerating the expiry date of all outstanding common share purchase warrants (the "Warrants") of the Company issued pursuant to the warrant indenture dated October 10, 2018 between the Company and Computershare Trust Company of Canada (the "Warrant Indenture"). The proceeds from the exercise of the Warrants will be primarily used by the Company to continue to execute on its growth strategy, as well as general corporate and working capital purposes.

  • New Research Study Proves Canadians Are Turning to Cannabis for Relaxation & Wellbeing
    PR Newswire2 months ago

    New Research Study Proves Canadians Are Turning to Cannabis for Relaxation & Wellbeing

    VANCOUVER, May 1, 2019 /PRNewswire/ - According to "The Future of Cannabis in Canada", a new study conducted by Insights West for Resonance Consultancy in partnership with Valens GroWorks Corp. (VGW.CN) (VGWCF), the Canadian cannabis consumer may choose to partake in the drug for a wide variety of reasons, including health benefits such as reducing anxiety, helping with sleep, and relieving stress. Clearly, even without clinical research, Canadians believe cannabis has a positive impact on their health and LP's should take note," said Everett Knight, Executive Vice President, Strategy and Investments for ValensGro. Among Canadian cannabis users, the top two reasons for consuming cannabis are to relax (79% regularly/occasionally) and for fun/recreation (74%), followed by to relieve stress (69%) and to help users sleep (60%).

  • Market Exclusive2 months ago

    Cannabis Stock News Daily Roundup April 30

    VIVO Cannabis (TSX-V: VIVO) (OTCQX: VVCIF) reported its fourth quarter and 2018 annual financial and operating results. The company had net sales of C$9.7 million for 2018, versus net sales of C$0.9 million for 2017. Net revenue for the fourth quarter was C$5.8 million, up from C$0.3 million in the same quarter of 2017. The Green Organic Dutchman […]The post Cannabis Stock News Daily Roundup April 30 appeared first on Market Exclusive.

  • Valens Receives Organic Certification for Cannabis Oil Production
    PR Newswire2 months ago

    Valens Receives Organic Certification for Cannabis Oil Production

    KELOWNA, BC , April 29, 2019 /PRNewswire/  - Valens GroWorks Corp. (CSE: VGW) (OTC: VGWCF)  (the " Company " or " Valens "), a multi-licensed, vertically integrated provider of cannabis ...

  • Valens Signs Multi-year Cannabis and Hemp Extraction agreement with HEXO Corp.
    CNW Group2 months ago

    Valens Signs Multi-year Cannabis and Hemp Extraction agreement with HEXO Corp.

    KELOWNA, BC , April 25, 2019 /CNW/ - Valens GroWorks Corp. (CSE: VGW, OTC: VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce that it has entered into an arm's length binding multi-year extraction services agreement (the "Agreement") to provide cannabis and hemp extraction services to HEXO Corp ("HEXO") (HEXO.TO) (HEXO), a leading cannabis producer and consumer packaged goods cannabis company.

  • Valens Reports Record $2.2 Million in Revenue in the First Quarter of Fiscal 2019
    PR Newswire2 months ago

    Valens Reports Record $2.2 Million in Revenue in the First Quarter of Fiscal 2019

    KELOWNA, BC, April 24, 2019 /PRNewswire/ - Valens GroWorks Corp. (VGW.CN) (VGWCF) (the "Company" or "Valens"), a multi-licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to report its financial results for the first quarter of fiscal 2019. Revenue increased to $2,220,200 for the first quarter of 2019 compared with $nil in the same period in fiscal 2018. Gross profit increased to $850,525, or 38.3% of revenue, for the first quarter of 2019 compared with $nil in the same period in fiscal 2018.